AVBP · Company research
ArriVent BioPharma, Inc. Common Stock (AVBP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| ArriVent BioPharma (AVBP) Securities Investigation Notice - Levi & Korsinsky - PR Newswire | ArriVent BioPharma (AVBP) Securities Investigation Notice - Levi & Korsinsky PR Newswire | View source ↗ | PR Newswire | Oct 13, 2026 | neutral | 0 | 0.6 |
| A cancer drug targets two proteins in ovarian and endometrial tumors. Its first patient has been dosed. - Stock Titan | A cancer drug targets two proteins in ovarian and endometrial tumors. Its first patient has been dosed. Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving ArriVent BioPharma (AVBP) - GlobeNewswire | Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving ArriVent BioPharma (AVBP) GlobeNewswire | View source ↗ | GlobeNewswire | Oct 9, 2026 | neutral | 0 | 0.6 |
| Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving ArriVent BioPharma (AVBP) - GlobeNewswire | Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving ArriVent BioPharma (AVBP) GlobeNewswire | View source ↗ | GlobeNewswire | Oct 9, 2026 | neutral | 0 | 0.6 |
| ArriVent BioPharma, Inc. (AVBP) stock price, news, quote and history - Yahoo Finance Singapore | ArriVent BioPharma, Inc. (AVBP) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 9, 2026 | neutral | 0 | 0.6 |
| AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’ - Stocktwits | AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’ Stocktwits | View source ↗ | Stocktwits | Oct 8, 2026 | neutral | 0 | 0.6 |
| ArriVent BioPharma, Inc. (AVBP) Stock Price, News, Quote & History - Yahoo! Finance Canada | ArriVent BioPharma, Inc. (AVBP) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Avbp stock hits 52-week low at 12.09 USD - Investing.com | Avbp stock hits 52-week low at 12.09 USD Investing.com | View source ↗ | Investing.com | Oct 7, 2026 | neutral | 0 | 0.6 |
| ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP) - PR Newswire | ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP) PR Newswire | View source ↗ | PR Newswire | Oct 6, 2026 | neutral | 0 | 0.6 |
| ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP) - yoursun.com | ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP) yoursun.com | View source ↗ | yoursun.com | Oct 6, 2026 | neutral | 0 | 0.6 |
| Why Is ArriVent BioPharma Stock Tumbling Today? - ArriVent BioPharma (NASDAQ:AVBP) - Benzinga | Why Is ArriVent BioPharma Stock Tumbling Today? - ArriVent BioPharma (NASDAQ:AVBP) Benzinga | View source ↗ | Benzinga | Oct 6, 2026 | neutral | 0 | 0.6 |
| AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’ - TradingView | AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’ TradingView | View source ↗ | TradingView | Oct 6, 2026 | neutral | 0 | 0.6 |
| Why ArriVent BioPharma (AVBP) Stock Is Down Today - Quiver Quantitative | Why ArriVent BioPharma (AVBP) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 6, 2026 | neutral | 0 | 0.6 |
| Why ArriVent BioPharma (AVBP) Stock Is Down Today - Quiver Quantitative | Why ArriVent BioPharma (AVBP) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 6, 2026 | neutral | 0 | 0.6 |
| ArriVent stock plunges on cancer trial failure (AVBP:NASDAQ) - Seeking Alpha | ArriVent stock plunges on cancer trial failure (AVBP:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 6, 2026 | neutral | 0 | 0.6 |
| AVBP Stock Holds Range As Cash-Rich Biotech Plans Next Move - Timothy Sykes | AVBP Stock Holds Range As Cash-Rich Biotech Plans Next Move Timothy Sykes | View source ↗ | Timothy Sykes | Oct 6, 2026 | neutral | 0 | 0.6 |
| AVBP Stock Holds Range As Cash-Rich Biotech Plans Next Move - timothysykes.com | AVBP Stock Holds Range As Cash-Rich Biotech Plans Next Move timothysykes.com | View source ↗ | timothysykes.com | Oct 6, 2026 | neutral | 0 | 0.6 |
| AVBP Stock Holds Range As Cash Runway Supports Biotech Story - StocksToTrade | AVBP Stock Holds Range As Cash Runway Supports Biotech Story StocksToTrade | View source ↗ | StocksToTrade | Oct 6, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.